Manufacturing, Fill/Finish

Sep 01, 2016
BioPharm International
Improvements to aseptic manufacturing procedures are long overdue. But how feasible is it for manufacturers to modernize fill lines of legacy products?
Aug 01, 2016
BioPharm International
Industry experts discuss the challenges of using single-use systems in biopharma manufacturing.
Jul 01, 2016
BioPharm International
CPhI Pharma Awards seek nominations for excellence in biopharma development and manufacturing.
May 01, 2016
BioPharm International
Material compatibility, material sourcing, facility layout, and training are crucial aspects of a successful disposable fill-finish system.
Nov 19, 2015
By BioPharm International Editors
Baxter expands capacity for lyophilized cytotoxic oncology therapies at its fill/finish facility in Halle, Germany.
Nov 19, 2015
By BioPharm International Editors
Baxter expands capacity for lyophilized cytotoxic oncology therapies at its fill/finish facility in Halle, Germany.
Nov 01, 2015
BioPharm International
Two experts discuss best practices to achieve acceptable sterility assurance levels for aseptically filled products.
Oct 15, 2015
By BioPharm International Editors
Althea is expanding its existing biological drug product manufacturing operations to include highly active materials, such as antibody-drug conjugates, in a new facility near San Diego, CA.
Oct 15, 2015
By BioPharm International Editors
Scottish injectable-drug manufacturer Symbiosis Pharmaceutical Services plans to expand its sterile filling facility.
Oct 07, 2015
The challenge of achieving zero visible defects (i.e., particulates) in parenteral drugs will require a coordinated effort at all stages of the supply chain, particularly in the production and filling of primary containers.
native1_300x100
lorem ipsum